Juarranz Y - Search Results

1

Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation.

Leceta J, Gomariz RP, Martinez C, Carrión M, Arranz A, Juarranz Y. Leceta J, et al. Among authors: juarranz y. Neuroimmunomodulation. 2007;14(3-4):134-8. doi: 10.1159/000110636. Epub 2007 Dec 5. Neuroimmunomodulation. 2007. PMID: 18073504 Review.

2

VIP-PACAP system in immunity: new insights for multitarget therapy.

Gomariz RP, Juarranz Y, Abad C, Arranz A, Leceta J, Martinez C. Gomariz RP, et al. Among authors: juarranz y. Ann N Y Acad Sci. 2006 Jul;1070:51-74. doi: 10.1196/annals.1317.031. Ann N Y Acad Sci. 2006. PMID: 16888149 Review.

3

VIP and tolerance induction in autoimmunity.

Rosignoli F, Torroba M, Juarranz Y, García-Gómez M, Martinez C, Gomariz RP, Pérez-Leirós C, Leceta J. Rosignoli F, et al. Among authors: juarranz y. Ann N Y Acad Sci. 2006 Jul;1070:525-30. doi: 10.1196/annals.1317.073. Ann N Y Acad Sci. 2006. PMID: 16888219

4

Vasoactive intestinal peptide as a healing mediator in Crohn's disease.

Arranz A, Abad C, Juarranz Y, Leceta J, Martinez C, Gomariz RP. Arranz A, et al. Among authors: juarranz y. Neuroimmunomodulation. 2008;15(1):46-53. doi: 10.1159/000135623. Epub 2008 Jul 29. Neuroimmunomodulation. 2008. PMID: 18667799 Review.

5

Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics.

Gomariz RP, Gutiérrez-Cañas I, Arranz A, Carrión M, Juarranz Y, Leceta J, Martínez C. Gomariz RP, et al. Among authors: juarranz y. Curr Pharm Des. 2010;16(9):1063-80. doi: 10.2174/138161210790963841. Curr Pharm Des. 2010. PMID: 20030612 Review.

6

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves' disease.

Carrión M, Ramos-Leví AM, Seoane IV, Martínez-Hernández R, Serrano-Somavilla A, Castro D, Juarranz Y, González-Álvaro I, Gomariz RP, Marazuela M. Carrión M, et al. Among authors: juarranz y. Sci Rep. 2020 Aug 3;10(1):13018. doi: 10.1038/s41598-020-70138-3. Sci Rep. 2020. PMID: 32747757 Free PMC article.

7

Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP.

Gomariz RP, Arranz A, Abad C, Torroba M, Martinez C, Rosignoli F, Garcia-Gómez M, Leceta J, Juarranz Y. Gomariz RP, et al. Among authors: juarranz y. J Leukoc Biol. 2005 Aug;78(2):491-502. doi: 10.1189/jlb.1004564. Epub 2005 Apr 27. J Leukoc Biol. 2005. PMID: 15857940

8

cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP.

Abad C, Juarranz Y, Martinez C, Arranz A, Rosignoli F, García-Gómez M, Leceta J, Gomariz RP. Abad C, et al. Among authors: juarranz y. Inflamm Bowel Dis. 2005 Jul;11(7):674-84. doi: 10.1097/01.mib.0000171872.70738.58. Inflamm Bowel Dis. 2005. PMID: 15973123

9

Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis.

Juarranz Y, Abad C, Martinez C, Arranz A, Gutierrez-Cañas I, Rosignoli F, Gomariz RP, Leceta J. Juarranz Y, et al. Arthritis Res Ther. 2005;7(5):R1034-45. doi: 10.1186/ar1779. Epub 2005 Jun 23. Arthritis Res Ther. 2005. PMID: 16207319 Free PMC article.

10

Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: implications for rheumatoid arthritis.

Gutiérrez-Cañas I, Juarranz Y, Santiago B, Martínez C, Gomariz RP, Pablos JL, Leceta J. Gutiérrez-Cañas I, et al. Among authors: juarranz y. Brain Behav Immun. 2008 Mar;22(3):312-7. doi: 10.1016/j.bbi.2007.09.007. Epub 2007 Oct 24. Brain Behav Immun. 2008. PMID: 17951026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page